Company
Aptinyx
Aptinyx has 3 drugs tracked on RxWires: 1 in Phase 2/3, 2 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| NYX-783 | Phase 2/3 | PTSD |
| NYX-458 | Phase 2 | Mild Cognitive Impairment |
| NYX-2925 50 mg | Phase 2 | Diabetic Peripheral Neuropathic Pain |
Latest
No recent events.
Follow Aptinyx on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.